GHRP-2 (Growth Hormone Releasing Peptide 2) is a synthetic peptide subject of growing interest in scientific circles, especially in biological and biochemical research. Its potential impact across ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects approximately 25% of the global population and is typically linked to obesity. Notably, emerging evidence indicates that 12%–20% of ...